Polish Registry of Takotsubo Syndrome
Launched by MEDICAL UNIVERSITY OF WARSAW · Nov 12, 2020
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
The Polish Registry of Takotsubo Syndrome is a clinical trial that aims to gather important information about a heart condition known as Takotsubo Syndrome. This condition, often referred to as "broken heart syndrome," can occur after stressful events and leads to temporary heart issues. The trial is currently recruiting participants of all ages and genders who have been diagnosed with Takotsubo Syndrome. There are no specific exclusions, meaning anyone with this condition may be eligible to join.
Participants in this trial can expect to contribute to a growing understanding of Takotsubo Syndrome, which may help improve future treatments and care for others with this condition. By joining the registry, patients will provide valuable information about their experiences, which could lead to better insights into how this syndrome affects people. If you or someone you know has Takotsubo Syndrome, this could be an important opportunity to help advance medical knowledge.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients with takotsubo syndrome
- Exclusion Criteria:
- • -
About Medical University Of Warsaw
The Medical University of Warsaw is a leading academic institution dedicated to advancing healthcare through innovative research and education. Renowned for its commitment to excellence in medical training and clinical practice, the university actively engages in a diverse range of clinical trials aimed at improving patient outcomes and enhancing medical knowledge. With a robust infrastructure and a multidisciplinary team of experts, the Medical University of Warsaw fosters collaboration in the development of novel therapies and interventions, contributing significantly to the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Warsaw, Poland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials